Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
since
auto-detected in 7 stories
39 days ago
found
5 months ago
As regulator prepares to approve lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’
A drug with the potential to “end the…
6 months ago
found
7 months ago
found
a story from The Guardian ⚠️ › International
Duke of York’s, London
A triumphant staging by Rebecca Lucy Taylor of her new album, A Complicated Woman, is part artistic statement, part power pop club night
Hard-edged digital club music throbs fro…
8 months ago
found
a story from The Guardian ⚠️ › International
Organisations that pumped money into overturning Roe v Wade are making inroads in Europe. Women’s rights are truly at risk
With Donald Trump as president, there is now a heavy strain of Christian nati…
page 1 of 1